Contineum Therapeutics, Inc. Class A Common Stock (CTNM) Stock Price
Contineum Therapeutics, Inc. Class A Common Stock (NASDAQ: CTNM) last traded at $17.19, up 7.30% on the session. The quote above updates while this page is open; the figures below are drawn from Contineum Therapeutics, Inc. Class A Common Stock’s own filings and are restated only when a new one is published.
Contineum Therapeutics, Inc. Class A Common Stock (CTNM) company overview
Contineum Therapeutics, Inc. Class A Common Stock trades on NASDAQ under the ticker CTNM. Its market capitalisation is $397.07 million.
CTNM valuation
Valuation measures for Contineum Therapeutics, Inc. Class A Common Stock, derived from the latest quote and its most recent SEC filing.
Market cap
$397.07M
Enterprise value
$393.07M
Price / book
1.66
Beta
1.09
CTNM financials
Trailing-twelve-month figures tagged in Contineum Therapeutics, Inc. Class A Common Stock's XBRL filings with the SEC.
Net income (TTM)
-$57.56M
Return on equity
-24.02%
Cash
$14.71M
CTNM trading statistics
Range and volume for CTNM over the past 52 weeks.
52-week high
$17.35
52-week low
$8.60
Volume
353.9K
Average volume
406.6K
Previous close
$16.02
Contineum Therapeutics, Inc. Class A Common Stock (CTNM) FAQs
What is the CTNM stock price today?
Contineum Therapeutics, Inc. Class A Common Stock (CTNM) last traded at $17.19, up 7.30% on the session. FurlPay quotes CTNM from Yahoo Finance and stamps each figure with the exchange time it printed.
What exchange is CTNM listed on?
Contineum Therapeutics, Inc. Class A Common Stock is listed on NASDAQ under the ticker symbol CTNM.
What is Contineum Therapeutics, Inc. Class A Common Stock's market cap?
Contineum Therapeutics, Inc. Class A Common Stock has a market capitalisation of $397.07 million, derived from its shares outstanding as reported in its SEC filings and the latest quoted price.
What is CTNM's 52-week range?
Over the past 52 weeks CTNM has traded between $8.60 and $17.35.
Data sources
Price, range and volume — Yahoo Finance. Quotes may be delayed; each carries the exchange timestamp it printed with.
Financials and valuation — the company’s own XBRL filings with the U.S. Securities and Exchange Commission (CIK 0001855175), period ending 2026-06-30.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.
CTNM Stock Price & Quote | Contineum Therapeutics, Inc. Class A Common Stock | FurlPay